Q3 2022 13F Holders as of 30 Sep 2022
-
Type / Class
-
Equity / COM
-
Shares outstanding
-
40,762,262
-
Total 13F shares
-
34,912,391
-
Share change
-
-441,376
-
Total reported value
-
$581,637,070
-
Put/Call ratio
-
253%
-
Price per share
-
$16.66
-
Number of holders
-
100
-
Value change
-
-$4,909,166
-
Number of buys
-
58
-
Number of sells
-
49
Institutional Holders of Pulmonx Corp - COM (LUNG) as of Q3 2022
As of 30 Sep 2022,
Pulmonx Corp - COM (LUNG) was held by
100 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
34,912,391 shares.
The largest 10 holders included
PRIMECAP MANAGEMENT CO/CA/, DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C), VANGUARD GROUP INC, Champlain Investment Partners, LLC, BlackRock Inc., MORGAN STANLEY, TimesSquare Capital Management, LLC, Jefferies Group LLC, BNP PARIBAS ASSET MANAGEMENT Holding S.A., and STATE STREET CORP.
This page lists
100
institutional shareholders reporting positions in this security
for the Q3 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.